[go: up one dir, main page]

PT805156E - Hidrato do acido 8-alcoxiquinolonocarboxilico com excelente estabilidade e processo para a sua producao - Google Patents

Hidrato do acido 8-alcoxiquinolonocarboxilico com excelente estabilidade e processo para a sua producao

Info

Publication number
PT805156E
PT805156E PT95938644T PT95938644T PT805156E PT 805156 E PT805156 E PT 805156E PT 95938644 T PT95938644 T PT 95938644T PT 95938644 T PT95938644 T PT 95938644T PT 805156 E PT805156 E PT 805156E
Authority
PT
Portugal
Prior art keywords
excellent stability
alcoxiquinolonocarboxylic
production
acid hydrate
piperazinyl
Prior art date
Application number
PT95938644T
Other languages
English (en)
Inventor
Yukihiro Kato
Toyomi Matsumoto
Masamoto Hara
Kunio Miyashita
Original Assignee
Kyorin Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=18290056&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT805156(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kyorin Seiyaku Kk filed Critical Kyorin Seiyaku Kk
Publication of PT805156E publication Critical patent/PT805156E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
PT95938644T 1994-12-21 1995-12-05 Hidrato do acido 8-alcoxiquinolonocarboxilico com excelente estabilidade e processo para a sua producao PT805156E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP33556994A JP3449658B2 (ja) 1994-12-21 1994-12-21 安定性に優れた８−アルコキシキノロンカルボン酸水和物並びにその製造方法

Publications (1)

Publication Number Publication Date
PT805156E true PT805156E (pt) 2002-09-30

Family

ID=18290056

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95938644T PT805156E (pt) 1994-12-21 1995-12-05 Hidrato do acido 8-alcoxiquinolonocarboxilico com excelente estabilidade e processo para a sua producao

Country Status (15)

Country Link
US (1) US5880283A (pt)
EP (1) EP0805156B1 (pt)
JP (1) JP3449658B2 (pt)
KR (1) KR100381644B1 (pt)
CN (1) CN1137890C (pt)
AT (1) ATE216381T1 (pt)
AU (1) AU694946B2 (pt)
CA (1) CA2208704C (pt)
DE (1) DE69526453T2 (pt)
DK (1) DK0805156T3 (pt)
ES (1) ES2173982T3 (pt)
HU (1) HU227795B1 (pt)
PT (1) PT805156E (pt)
TW (1) TW393479B (pt)
WO (1) WO1996019472A1 (pt)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19820801A1 (de) * 1998-05-09 1999-11-25 Gruenenthal Gmbh Orale Arzneiformen mit reproduzierbarer Wirkstofffreisetzung von Gatifloxacin oder pharmazeutisch verwendbaren Salzen oder Hydraten
GB9820405D0 (en) * 1998-09-18 1998-11-11 Smithkline Beecham Plc Process
GB9920917D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel process
GB9920919D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel compound
TWI287987B (en) * 2000-08-14 2007-10-11 Senju Pharma Co Cytokine inhibitor
US6413969B1 (en) * 2000-09-13 2002-07-02 Bristol-Myers Squibb Company Gatifloxacin pentahydrate
JP2002363172A (ja) * 2001-06-05 2002-12-18 Showa Denko Kk ５−アルキルオキサゾリジン−２，４−ジオンの製造方法
US6589955B2 (en) * 2001-06-20 2003-07-08 Bristol-Myers Squibb Company Pediatric formulation of gatifloxacin
KR100517638B1 (ko) 2002-04-08 2005-09-28 주식회사 엘지생명과학 게미플록사신 산염의 새로운 제조방법
ES2248743T3 (es) * 2002-04-08 2006-03-16 Dr. Reddy's Laboratories Ltd. Formas cristalinas anhidras i y ii del acido 1-ciclopropil-6-fluoro-8-metoxi-7-(-3-metil-1-piperazinil)-4-oxo-1,4-dihidroquinolin-3-carboxilico (gatifloxacina).
AU2003232113A1 (en) * 2002-05-10 2003-11-11 Teva Pharmaceutical Industries Ltd. Novel crystalline forms of gatifloxacin
EP1645274A1 (en) * 2002-05-10 2006-04-12 Teva Pharmaceutical Industries Ltd. Process for making gatifloxacin form omega
US7423153B2 (en) 2002-05-10 2008-09-09 Teva Pharmaceutical Industries Ltd. Crystalline forms of gatifloxacin
CN1674902A (zh) * 2002-06-14 2005-09-28 特瓦制药工业有限公司 新晶型的加替沙星
WO2004012739A1 (en) * 2002-08-06 2004-02-12 Teva Pharmaceutical Industries Ltd. Novel crystalline forms of gatifloxacin
PL375437A1 (en) * 2002-08-14 2005-11-28 Teva Pharmaceutical Industries Ltd. Synthesis of gatifloxacin
AU2003300874A1 (en) * 2002-12-12 2004-07-09 Teva Pharmaceutical Industries Ltd. Crystalline forms of gatifloxacin and processes for preparation
WO2004087688A1 (en) * 2003-04-02 2004-10-14 Hetero Drugs Limited Novel crystalline forms of gatifloxacin
AU2003304118A1 (en) * 2003-05-19 2004-12-03 Hetero Drugs Limited Purification methods of gatifloxacin and a novel form of gatifloxacin
WO2005021000A1 (en) * 2003-08-28 2005-03-10 Ranbaxy Laboratories Limited Solid oral dosage forms of gatifloxacin
ES2232310B1 (es) * 2003-11-13 2006-08-01 Quimica Sintetica, S.A. Formula cristalina no higroscopica de gatifloxacino.
ES2232311B1 (es) * 2003-11-13 2006-08-01 Quimica Sintetica, S.A. Forma cristalina de gatifloxacino.
US7781585B2 (en) 2004-06-04 2010-08-24 Matrix Laboratories Ltd Crystalline forms of Gatifloxacin
US20090156577A1 (en) * 2004-09-09 2009-06-18 Benjamin Davis 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
US20060247255A1 (en) * 2005-05-02 2006-11-02 Patel Satishkumar A Method for preparing a stable gatifloxacin composition
US20080139574A1 (en) 2006-11-30 2008-06-12 Cadila Healthcare Limited Novel quinoline derivatives
CA2621616A1 (en) * 2007-02-19 2008-08-19 Alcon Research, Ltd. Topical gatifloxacin formulations
US7902227B2 (en) 2007-07-27 2011-03-08 Janssen Pharmaceutica Nv. C-7 isoxazolinyl quinolone / naphthyridine derivatives useful as antibacterial agents
WO2009064792A1 (en) * 2007-11-16 2009-05-22 Cumbre Pharmaceuticals Inc. Quinolone carboxylic acid-substituted rifamycin derivatives
US8629178B2 (en) * 2009-11-03 2014-01-14 Li Liu Sodium tanshinone IIA sulfonate hydrate and preparation method and use thereof
CN102757419B (zh) * 2012-08-08 2015-03-11 四川百利药业有限责任公司 一种加替沙星的纯化方法
MX388561B (es) 2013-03-15 2025-03-11 Melinta Subsidiary Corp Metodos para tratar infecciones en pacientes obesos y con sobrepeso usando antibioticos.
EP3496662A4 (en) 2016-08-12 2019-10-30 Silk Technologies Ltd. SILICONE PROTEIN FOR THE TREATMENT OF IGNITION

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3985747A (en) * 1974-05-24 1976-10-12 Bristol-Myers Company Crystalline sesquihydrate of 7-[D-α-amino-α-(p-hydroxyphenyl)acetamido]-3-(1,2,3-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid
JPS57134482A (en) * 1981-02-13 1982-08-19 Dainippon Pharmaceut Co Ltd 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8- naphthyridine-3-carboxylic acid-3/2 hydrate and its preparation
DE3248506A1 (de) * 1982-12-29 1984-07-05 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7(alkyl-1-piperazinyl)-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
JPH089597B2 (ja) * 1986-01-21 1996-01-31 杏林製薬株式会社 選択毒性に優れた８‐アルコキシキノロンカルボン酸およびその塩並びにその製造方法
JPS62205060A (ja) * 1986-03-04 1987-09-09 Kyorin Pharmaceut Co Ltd ８位置換キノロンカルボン酸誘導体
FI871419L (fi) * 1986-03-31 1987-10-01 Sankyo Co Kinolin-3-karboxylsyraderivat, deras framstaellning och anvaendning.
JPS63198664A (ja) * 1986-03-31 1988-08-17 Sankyo Co Ltd キノロンカルボン酸誘導体
ATE207479T1 (de) * 1992-01-31 2001-11-15 Chugai Pharmaceutical Co Ltd Kristalle von derivaten von chinozon carbonsäure- hydraten

Also Published As

Publication number Publication date
AU3994695A (en) 1996-07-10
DK0805156T3 (da) 2002-05-06
ES2173982T3 (es) 2002-11-01
HU227795B1 (en) 2012-03-28
DE69526453D1 (de) 2002-05-23
CA2208704A1 (en) 1996-06-27
CA2208704C (en) 2005-05-03
HUT77945A (hu) 1998-12-28
EP0805156A4 (en) 1998-04-15
TW393479B (en) 2000-06-11
WO1996019472A1 (en) 1996-06-27
CN1137890C (zh) 2004-02-11
KR100381644B1 (ko) 2003-08-30
DE69526453T2 (de) 2002-12-12
CN1171108A (zh) 1998-01-21
US5880283A (en) 1999-03-09
AU694946B2 (en) 1998-08-06
ATE216381T1 (de) 2002-05-15
EP0805156B1 (en) 2002-04-17
JPH08176143A (ja) 1996-07-09
EP0805156A1 (en) 1997-11-05
JP3449658B2 (ja) 2003-09-22

Similar Documents

Publication Publication Date Title
PT805156E (pt) Hidrato do acido 8-alcoxiquinolonocarboxilico com excelente estabilidade e processo para a sua producao
ES533916A0 (es) Un metodo para producir acidos 1,4-dihidro-4-oxo-quinolin-3-carboxilico
ATE183993T1 (de) Zwischenprodukte für die herstellung einer substituierten 2,5-diamino-3-hydroxyhexan.
ATE415394T1 (de) Zwischeprodukte zur herstellung von retroviralen protease-hemmern
DE69226822D1 (de) Diastereomeres Salz von optisch aktiver Chinolinmevalonsäure
CA2109482A1 (en) Process for producing alanylglutamine
DE60200535D1 (de) Verfahren zur Herstellung von hoch reinem Pemirolast
BRPI0013751B8 (pt) processo para produção de derivados de ácido naftiridina-3-carboxílico.
PT945430E (pt) N-fenilacetoacetamidas e processo para a sua producao
BR8802830A (pt) Processo para a preparacao de amidas de acido 3,3-diaril-acrilico
DE69503093D1 (de) Verfahren zur Herstellung von Guaniden
BR9406352A (pt) Processo para a fabricição de ácido aminometanofosfonico
ATE554094T1 (de) Verfahren zur herstellung von 3-cephem- verbindungen
ATE103276T1 (de) Verfahren zur herstellung von chinolin-2,3carbons|ure.
BR9907340A (pt) Ciclo-heptenos substituìdos, e processo para a produção de um composto
ATE311382T1 (de) Verfahren zur herstellung von 2-carbamoyl- pyridinen
DE69315712D1 (de) 2,4-Diamino-1,3,5-Triazinyl-6-Phosphonsäurederivate
PT1234817E (pt) Processo para a preparacao de midodrina
BR9403998A (pt) Processo para preparar um composto obtido
BR9405262A (pt) Processo para a preparação de um ácido piridina-2,3-dicarboxílico
ATE123279T1 (de) Substituierte 9-amino-spiro(cycloalkyl(b>chinolin-2,1'cycloal ane>, verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung als arzneimittel.
DE69113980D1 (de) Ein die umwelt nicht verunreinigendes verfahren zur herstellung von aromatischen nitroverbindungen ohne verwendung von mineralsäure.
BR9500801A (pt) N-aclioxialquil-carboxamidas puras isoladas e processo para a sua preparação
PT90832A (pt) Processo para a preparacao do acido 1-ciclopropil-6-fluoro-1,4-dihidro-4-oxo-7-(piperazinil)-quinolino-3-carboxilico (ciprofloxazina)
PT818464E (pt) Metilsulfomicina i processo para a sua producao e utilizacao